CADVANA Trademark

Trademark Overview

On Wednesday, May 25, 2011, a trademark application was filed for CADVANA with the United States Patent and Trademark Office. The USPTO has given the CADVANA trademark a serial number of 85329720. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 12, 2015. This trademark is owned by Glaxo Group Limited. The CADVANA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
cadvana

General Information

Serial Number85329720
Word MarkCADVANA
Filing DateWednesday, May 25, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 12, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 31, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, January 12, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 12, 2015ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 17, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 16, 2014EXTENSION 5 GRANTED
Monday, May 12, 2014EXTENSION 5 FILED
Monday, May 12, 2014TEAS EXTENSION RECEIVED
Friday, December 13, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 12, 2013EXTENSION 4 GRANTED
Monday, December 2, 2013EXTENSION 4 FILED
Monday, December 2, 2013TEAS EXTENSION RECEIVED
Saturday, June 8, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 7, 2013EXTENSION 3 GRANTED
Tuesday, May 28, 2013EXTENSION 3 FILED
Tuesday, May 28, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, November 30, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 29, 2012EXTENSION 2 GRANTED
Tuesday, November 27, 2012EXTENSION 2 FILED
Thursday, November 29, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 27, 2012TEAS EXTENSION RECEIVED
Friday, May 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 16, 2012EXTENSION 1 GRANTED
Wednesday, May 16, 2012EXTENSION 1 FILED
Wednesday, May 16, 2012TEAS EXTENSION RECEIVED
Tuesday, December 6, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 11, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2011PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 6, 2011ASSIGNED TO EXAMINER
Tuesday, May 31, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, May 28, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

cadvana pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological